Keith Merrell - Nu Med CFO, Secretary and Treasurer
| NUMD Stock | USD 0.01 0 10.00% |
CFO
Mr. Keith L. Merrell is Chief Financial Officer, Treasurer, Secretary of NUMED Plus, Inc. Mr. Merrell serves as our Chief Financial Officer, Secretary and Treasurer. Mr. Merrell draws on over 35 years of accounting experience to manage our accounting functions and interface with our independent public accountants. He spent two years in the field of public accounting and has served as Chief Financial Officer for four other public companies. He currently serves fulltime as our Chief Financial Officer and also serves as parttime CFO of another public company. His business career includes extensive experience in management, sales and marketing, consulting, and merger and acquisition work. He graduated from Arizona State University with a B.S degree in Accounting. since 2018.
| Age | 77 |
| Tenure | 6 years |
| Phone | 801 746 3570 |
| Web | https://www.nu-medplus.com |
Nu Med Management Efficiency
The company has return on total asset (ROA) of (6.6198) % which means that it has lost $6.6198 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (545.2325) %, meaning that it created substantial loss on money invested by shareholders. Nu Med's management efficiency ratios could be used to measure how well Nu Med manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CFO Age | ||
| Jereme CPA | DexCom Inc | 44 | |
| Craig Shore | InspireMD | 63 | |
Management Performance
| Return On Equity | -545.23 | |||
| Return On Asset | -6.62 |
Nu Med Plus Management Team
Elected by the shareholders, the Nu Med's board of directors comprises two types of representatives: Nu Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NUMD. The board's role is to monitor Nu Med's management team and ensure that shareholders' interests are well served. Nu Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Hayde, CEO Pres | ||
| Keith Merrell, CFO, Secretary and Treasurer | ||
| Craig MD, Chair Committee |
NUMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Nu Med a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -545.23 | |||
| Return On Asset | -6.62 | |||
| Current Valuation | 1.63 M | |||
| Shares Outstanding | 81.35 M | |||
| Shares Owned By Insiders | 61.99 % | |||
| Price To Earning | 19.00 X | |||
| Price To Book | 49.86 X | |||
| EBITDA | (808.68 K) | |||
| Net Income | (830.06 K) | |||
| Cash And Equivalents | 2.54 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in NUMD OTC Stock
Nu Med financial ratios help investors to determine whether NUMD OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NUMD with respect to the benefits of owning Nu Med security.